Tumor inhibitors. 124. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids

Authors:
  • SKS. Morris Kupchan
    S. Morris Kupchan
  • ASAlbert T. Sneden
    Albert T. Sneden
  • ABAlan R. Branfman
    Alan R. Branfman
  • GHGary A. Howie
    Gary A. Howie
  • LRLionel I. Rebhun
    Lionel I. Rebhun
  • WMWilson E. McIvor
    Wilson E. McIvor
  • RWRegina W. Wang
    Regina W. Wang
  • TSTerry C. Schnaitman
    Terry C. Schnaitman

Abstract
Note: In lieu of an abstract, this is the article's first page.